Then we used dualluciferase reporter gene assay, RIP assay as well as RNApull-down assay to confirm that miR-202 was a directtarget of MALAT1. MiR-202, a new tumor suppressor,is down-regulated in gastric cancer (32). This evidence concerns the gene MALAT1 and neoplasm.